PhI/II FirstInHuman Study DF9001 Comb w/Nivolumab Pa w/Solid Tumors Selected IndicationsJennifer Brooke ValerinOPEN TO ACCRUALGet More Information
Evaluate Satralizumab as Monotherapy or in Addition to Baseline Therapy in Patients with MOGADMichael SyOPEN TO ACCRUALGet More Information
PhI/Ib FirstInHuman Investig SafeTolerabPharmBiologic&ClinicalActiv DF6215 Pa w/Adv Solid TuJennifer Brooke ValerinOPEN TO ACCRUALGet More Information
PhI Study PolymeraseThetaInhibitor Novobiocin BRCAMutant&Other DNADamageRepair-Deficient SolidTumorsJennifer Brooke ValerinOPEN TO ACCRUALGet More Information
Ph II Subcutan Amivantamab in Pts w/ Adv or Metastat SolidTumors EGFR-mutated Non-Small Cell Lung CaMisako NagasakaOPEN TO ACCRUALGet More Information
Phase 2 Study of EDG-5506 in Becker Muscular Dystrophy (GRAND CANYON)Tahseen MozaffarOPEN TO ACCRUALGet More Information
PhII NanO2TM Combo w/Rad&Temozolomide Pa w/NewlyDia GlioblsdtomaMultiforme: RESTOREXiao-Tang KongOPEN TO ACCRUALGet More Information
Double-Blind use of Staccato Alprazolam for participants with prolonged seizures Lilit MnatsakanyanOPEN TO ACCRUALGet More Information
Advarra Reliance #26: Neuromuscular Observational Research (MOVR) Data Hub Protocol Pro00034893 Tahseen MozaffarOPEN TO ACCRUALGet More Information
PhI DoseEscalationExpandedCohort P-MUC1C-ALLO1 AdultSubjects AdvancedMeta SolidTumorsRita MehtaOPEN TO ACCRUALGet More Information
A Randomized Study of XEN1101 Versus Placebo in Focal-Onset SeizuresMona SazgarOPEN TO ACCRUALGet More Information
A Study to Evaluate PF-06823859 in People With Active Idiopathic Inflammatory MyopathiesNamita GoyalOPEN TO ACCRUALGet More Information
PhII Study of Tirabrutinib in Patients with Primary Central Nervous System Lymphoma Daniela BotaOPEN TO ACCRUALGet More Information
Venglustat on neuropathic and abdominal pain in male and female adults with Fabry diseaseChangrui XiaoOPEN TO ACCRUALGet More Information